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Abstract
Background: In this study, we defined the population biology of serogroup 6 Streptococcus pneumoniae collected
in China and their antibiotic resistance profiles.
Methods: The serotypes of 225 S. pneumoniae strains isolated between 1997 and 2011 were identified with the
Quellung reaction and serotype-specific PCR. All isolated pneumococci were tested for their sensitivity to 11 kinds
of antibiotics with the E-test method or disc diffusion. The sequence types (STs) were analyzed with multilocus
sequence typing (MLST).
Results: The frequencies of serotypes and subtypes 6A, 6B-I, 6B-II, 6C, and 6D among the 225 isolates were 46.7%
(105/225), 19.6% (44/225), 25.8% (58/225), 6.2% (14/225), and 1.8% (4/225), respectively. Serotype 6E was not found
in the serotype 6A isolates, and neither serotype 6F nor 6G was identified in any isolate. MLST analysis revealed
58 STs. The most common STs were ST982 (23.1%), ST90 (14.7%), ST4542 (7.6%), and ST2912 (4.9%). The rates of clonal
complex 90 (CC90) and CC386 among the oral-penicillin-nonsusceptible isolates decreased over the years, whereas the
rates of CC855 and CC3173 increased. The four CCs had similar penicillin MIC distributions, with a maximum MIC of
2 μg/ml.
Conclusions: This study identified the serotypes/subtypes and CCs/STs of group 6 S. pneumoniae present in China. No
salient antibiotic-resistant clones were isolated among the serogroup 6 S. pneumoniae.
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Background
Streptococcus pneumoniae remains the leading cause of
community-acquired respiratory infections, and is one of
the most important human pathogens causing severe in-
vasive infections [1]. So far, more than 90 pneumococcal
serotypes, classified into 46 groups, have been identified.
Serogroup 6 is one of the most common causes of inva-
sive pneumococcal disease in unvaccinated populations.
Serogroup 6 traditionally comprises two serotypes, 6A
and 6B. Two new serotypes, 6C and 6D, previously identi-
fied as serotype 6A and 6B, respectively, by the Quellung
reaction were identified as two distinct serotypes using a
multibead assay with monoclonal antibodies [2,3]. A fac-
tor antiserum, 6d, was then developed against these two
new serotypes. Therefore, these two serotypes can now be
identified with the traditional Quellung test [4,5]. Two
subtypes of 6B, designated 6B-I and 6B-II, can be distin-
guished by polymerase chain reaction (PCR) [6]. Another
study in Korea demonstrated that some serogroup 6 iso-
lates encode distinctive cps (capsular) loci, differing from
those of most other serogroup 6 isolates. These were des-
ignated the “6X” group, and include both traditional sero-
type 6A and 6B isolates [7]. Based on the differences in
their capsular gene sequences, serotype “6E” was assigned
to this group in a subsequent study [8]. In a German
epidemiological survey, two serogroup 6 isolates could
not be assigned to a serotype using factor sera [9]. The
latest report by Oliver et al. [10] showed that the two
isolates were assigned to new serotypes, “6F” and “6G”.
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That study showed that a single codon change in the cps
gene, encoding a glycosyl transferase, altered the sub-
strate specificity, caused the biosynthesis of heteroge-
neous capsule repeating units, and resulted in a new
hybrid capsule type. Antigenic formulae and specific
factor antisera against serotypes “6E”, “6F”, and “6G”
have not yet been developed, but are necessary for their
traditional serotype classification [11]. Because the new
serotypes have not been confirmed with the traditional
Quellung test, they are designated with quotation marks
in the present text.
We did not want to investigate the effects of the vaccine
PCV7, because its immunization coverage is too low
(<1%) to reflect its effectiveness. We set out to identify
any new serotypes (serotypes “6E”, “6F”, and “6G”) in ser-
ogroup 6 S. pneumoniae in China and to report the popu-
lation biology of this group. In our previous study [12], we
examined the genetic structures of only serotypes 6C and
6D, without the most frequent serotypes 6A and 6B. In
the present study, we report the STs of all the serogroup 6
isolates and an association between the STs and antibiotic
resistance. We intended to use identical isolates in these
two studies, but some isolates from our previous study
were dead when we went to include them in the present
study. Therefore, the present study includes some new
isolates collected in 2008–2011 from Shenzhen and
Beijing. There were differences in the antibiotic resistance
in different clones. For completeness, some published data
or similar information from our previous paper have been
included in the present results, but these are not included
in the analysis or discussion.
Methods
Pneumococcal isolates
A total of 225 serogroup 6 S. pneumoniae strains isolated
from children in 1997–2011 were included in the study.
The details of these S. pneumoniae collections have been
published previously [13-18]. The isolates were cultured
from nasopharyngeal specimens, except those collected
from Beijing in 2006–2008 and from Shenzhen in 2009–
2011, which were cultured from hypopharyngeal aspirate
specimens. All isolates were identified as serotypes 6A,
6B, 6C, and 6D with a capsule Quellung test using a pneu-
motest kit and specific factor antisera (Statens Serum
Institut, Copenhagen, Denmark). Typing was performed
with phase-contrast microscopy, according to previously
reported procedures [19].
A parent and/or legal guardian of each participant
signed a written informed consent document before
enrollment and before any study procedure was per-
formed. This study was viewed and approved by the
Ethics Committee of Beijing Children’s Hospital Affiliated
to Capital Medical University. No ethical problems existed
in this study.
PCR identification of 6A, 6B-I, 6B-II, 6C, 6D, “6E”, “6F”,
and “6G”
Chromosomal DNA was extracted from overnight cul-
tures of S. pneumoniae isolates grown on 5% trypticase
soy agar (Oxoid Ltd, Basingstoke, England) using the
SiMax™ Genomic DNA Extraction Kit (SBS Genetech
Co., Ltd), according to the manufacturer’s instructions.
The 6C isolates were differentiated from the 6A and
“6E” isolates using PCR with primers 5106 and 3101,
as described previously [6,7,20], which generated a 1.8-
kilobase-pair (kbp) amplicon for 6C and a 2.0-kbp or
2.3-kbp amplicon for 6A or “6E”, respectively. This pair
of primers was also used to differentiate the 6D cps locus
from that of 6B, generating a 1.8-kbp amplicon for 6D
and a 2.0-kbp or 2.3-kbp amplicon for subtypes 6B-I or
6B-II, respectively. The primers 5101 and 3101 used to
differentiate 6A and “6E”, as well as 6B-I and 6B-II,
more definitively generated a 956-bp amplicon for 6A/
6B-I and a 1.2-kbp amplicon for “6E”/6B-II [6,7]. The
PCR procedures were as previously described [20]. All
serotype 6A and 6B isolates were retested against the
factor antiserum 6d and all serotype 6C and 6D isolates
were retested against factor 6b or 6c to identify serotype
“6 F” or “6G”, respectively, which could not be assigned
to serotype 6A or 6C and 6B or 6D, respectively. All iso-
lates that reacted with factor 6d were subjected to PCR
amplification for wciP locus with primers 5106/3101 and
wciN locus with primers 5108/3107, as reported previously,
to identify serotypes “6 F” and “6G”, respectively [21].
Antimicrobial susceptibility
The minimum inhibitory concentrations (MICs) of all iso-
lates were determined for penicillin, amoxicillin–clavulanic
acid, ceftriaxone, cefuroxime, erythromycin, imipenem,
levofloxacin, and vancomycin using E-test strips (AB Biodisk,
Solna, Sweden), and their susceptibility to tetracycline,
sulfamethoxazole–trimethoprim, and chloramphenicol
was assessed with disc diffusion tests (Oxoid). The use of
the penicillin parenteral (nonmeningitis) breakpoints for
susceptible, intermediate, and resistant rates to compare
penicillin susceptibilities in this study blurred the differ-
ences between the serotypes [22]. Therefore, the oral peni-
cillin V breakpoints were also used to analyze penicillin
susceptibility. Streptococcus pneumoniae ATCC49619 was
used as the reference strain in the susceptibility tests. Iso-
lates were considered multidrug resistant if they were not
susceptible to three or more classes of antimicrobials.
Molecular epidemiology of serogroup 6 strains
All strains were characterized with multilocus sequence
typing (MLST). Bacterial chromosomal DNA was ex-
tracted as described above. The PCR fragments of the
seven MLST genes (aroE, gdh, gki, recP, spi, xpt, and ddl)
were amplified from the chromosomal DNA. The products
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were sent to BGI Company (Beijing, China) for sequencing
on both strands. The STs were determined by comparing
the allelic profiles with the recognized STs at the MLST
website (http://spneumoniae.mlst.net). The new alleles and
allelic profiles identified in the present study have been
submitted to the MLST database for name assignment.
The eBURST v3 software (available at http://www.mlst.net)
was used to estimate the relationships among the iso-
lates and to assign strains to a clonal complex (CC)
using the stringent group definition of six of seven shared
alleles [23].
Statistical analysis
The serotyping and antimicrobial resistance data were
analyzed with the WHONET 5.3 software, as recom-
mended by the World Health Organization (http://www.
who.int/drugresistance/whonetsoftware/en/). The χ2 test,
performed with the SPSS software v. 13.0 (SPSS Inc.
USA), was used for statistical comparisons. A two-tailed
cut-off of P < 0.05 was deemed to indicate statistical
significance.
Results
Serotype/subtype distributions and antibiotic
susceptibility
Among the 225 isolates identified as serogroup 6 S. pneu-
moniae, the rates of serotypes and subtypes 6A, 6B-I,
6B-II, 6C, and 6D were 46.7% (105/225), 19.6% (44/225),
25.8% (58/225), 6.2% (14/225), and 1.8% (4/225), respect-
ively. PCR analysis of the serotype 6A isolates with
primers 5106/3101 or 5101/3101 always generated the
same amplicons as the PCR analysis of 6B-I, indicating
that no serotype “6E” was present in the serotype 6A
isolates. No isolate was assigned ambiguously to 6A or 6C
or to 6B or 6D. The 14 serotype 6C isolates had identical
wciP and wciN sequences. The four serotype 6D isolates
also had identical wciP and wciN sequences. The length
of wciP was the same as that of the reference sequence
CR931638, with 10 random mutations. All wciN se-
quences were 1125 bp long and were identical to the
published 6C sequence (JF911510), which is longer than
that of CR931638 (945 bp). No wciN sequence in the
present study suggested serotype “6F” or “6G”.
The analysis of antibiotic resistance revealed similar
results to those in our previous report [12], which are
shown in the tables with no further description.
MLST
The MLST analysis revealed 58 STs, the most common
of which were ST982 (52 isolates, 23.1%), ST90 (33,
14.7%), ST4542 (17, 7.6%), and ST2912 (11, 4.9%). In
this study, we identified eight new STs, ST8617–ST8623
and ST8742, and a novel gki locus (gki383 in ST8742).
An eBURST analysis identified eight CCs and 26 singletons
(Figure 1). Two of the common STs, ST982 and ST2912,
were singletons. Six CCs each included 10 or more isolates:
CC90 (41 isolates), CC4542 (25 isolates), CC4536 (15
isolates), CC2754 (15 isolates), CC386 (10 isolates),
and CC8616 (10 isolates). ST982, ST2912, and these
six CCs accounted for 79.6% of all the isolates tested.
The distribution of the CCs/STs of the serogroup 6 S.
pneumoniae isolates according to serotype/subtype is
shown in Table 1 and Figure 1. Each serotype/subtype
had a main CC/ST that included the majority of the
isolates in the serotype/subtype. For instance, the propor-
tion of ST982 in the serotype 6A isolates (44.8%) was
Figure 1 Population snapshot of 225 S. pneumoniae strains revealed by an eBURST analysis. Lines indicate the presence of single-locus-variant
links in particular sequence types, indicated by circles. The size of the circle corresponds to the number of isolates belonging to the sequence type
(ST). The green ST numbers indicate serotype 6A or 6C isolates, the black numbers indicate 6B or 6D isolates, and the pink numbers indicate isolates
from the two groups.
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much higher than that of any other CC/ST (≤13.3%).
Some CCs/STs included several isolates belonging to dif-
ferent serotypes. Most of the ST982 isolates were identi-
fied as serotype 6A (47/52); and the other five isolates
were serotypes 6C (1/52) and 6D (4/52). Thus, all four 6D
isolates were ST982. Serotypes 6A and 6B were both
detected in the following STs: ST4542 (6A: 3/17; 6B:
14/17), ST2754 (6A: 2/6, 6B: 4/6), ST3173 (6A: 6/7, 6B:
1/7), ST4536 (6A: 3/4, 6B: 1/4), and ST8616 (6A: 3/4,
6B: 1/4). Other STs could only be detected in one serotype.
The CC/ST distributions of the serogroup 6 S. pneumo-
niae changed significantly during the study period. The
common CCs/STs, such as ST982, CC90, CC4542, and
CC4536, mainly occurred in 1997–2005, but these isolates
decreased or even disappeared in later years. Two CCs
among the common CCs/STs, CC2754 and CC386, were
mainly found in 2006–2010, with some fluctuations. No
CC or ST showed a clearly increasing trend, except the
group involving the infrequent “other” CCs/STs (“others”
in Table 1). Considerable isolates identified in this study
belonged to the infrequent “other” CCs/STs (46/225),
especially in 2009–2011 (10/26).
Associations between STs/CCs and antimicrobial resistance
The numbers and percentages of isolates not susceptible
to oral penicillin and other antibiotics are summarized
according to CCs/STs in Tables 2 and 3. Notably, all
CC90 isolates were not susceptible to oral penicillin,
with high MIC50 and MIC90 values, whereas other com-
mon CCs/STs were usually susceptible, except that some
intermediately susceptible strains (40.0%) were present
in CC386. More than half the infrequent “other” CC/ST
isolates were not susceptible to oral penicillin. High rates
of nonsusceptibility to cefuroxime were found in CC90
(92.7%) and the infrequent “other” CCs/STs (45.6%). The
differences in some other antimicrobial resistances be-
tween the CCs/STs are shown in Table 3.
The distributions of serotypes/subtypes and CCs/STs
in the oral-penicillin-nonsusceptible strains (OPNSP)
were analyzed further, as shown in Table 4. Although
6B-II was the main subtype in the total OPNSP strains,
its proportion decreased from 82.1% in 2000–2002 to
41.7% in 2009–2011 (χ2 = 5.6, P < 0.05). The proportion
of serotype 6A strains increased significantly from 10.3%
to 50.0% during the same period (χ2 = 6.8, P < 0.01). The
constitution of CCs/STs among the OPNSP also changed.
The proportions of CC90 and CC386 that were identified
as subtype 6B-II decreased. However, the proportions of
CC855 (including six serotype 6A isolates) increased, as
did the proportions of CC3173 (including six serotype
6A isolates and two subtype 6B-I isolates). The distribu-
tion of penicillin MICs between the CCs/STs did not
differ, except that the MICs of the CC386 isolates
reached 0.125 μg/ml.
Table 1 Distributions of CCs/STs of serogroup 6 S. pneumoniae by serotype/subtype
Types No. ST982 CC90 CC4542 CC4536 CC2754 ST2912 CC8616 CC386 Others
6A 105 47(44.8%) 0 3(2.9%) 14(13.3%) 6(5.7%) 2(1.9%) 9(8.6%) 0 24(22.9%)
6B-I 44 0 0 20(46.5%) 1(2.3%) 9(20.9%) 0 1(2.3%) 0 12(27.9%)
6B-II 58 0 41(69.5%) 1(1.7%) 0 0 0 0 10(16.9%) 7(11.9%)
6C 14 1(7.1%) 0 1(7.1%) 0 0 9(64.3%) 0 0 3(21.4%)
6D 4 4(100%) 0 0 0 0 0 0 0 0
Total 225 52(23.1%) 41(18.2%) 25(11.1%) 15(6.7%) 15(6.7%) 11(4.9%) 10(4.4%) 10(4.4%) 46(20.4%)
Note: %, number of serotypes/subtypes divided by number of CCs/STs.
Table 2 Penicillin susceptibility in serogroup 6 S. pneumoniae by CCs/STs
CCs/STs No. isolates Oral penicillin breakpoints MIC50 (μg/mL) MIC90 (μg/mL) MIC range (μg/mL)
I R
ST982 52 0 0 0.032 0.049 0.001–0.064
CC90 41 36(87.8%) 5(12.2%) 1 1.5 0.25–2
CC4542 25 0 0 0.016 0.023 0.003–0.032
ST2912 11 0 0 0.032 0.049 0.016–0.049
CC4536 15 0 0 0.016 0.032 0.016–0.064
CC2754 11 0 0 0.023 0.032 0.008–0.064
CC8616 10 0 0 0.016 0.023 0.002–0.023
CC386 10 4(40.0%) 0 0.064 0.125 0.032–0.125
Others 46 22(47.8%) 4(8.7%) 0.19 0.75 0.008–2
Total 225 63(28.0%) 9(4%) 0.032 1 0.001–2
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Discussion
Recently, Ko et al. [8] identified a distinct group among
serotypes 6A and 6B S. pneumoniae isolates, designated
serotype “6E”. Based on sequence data, the serotype “6E”
isolates from traditional serotype 6B were the same as
those from subtype 6B-II in the present study, which is
exactly consistent with subtype 6B-III reported by
Elberst et al. [24]. Subtype 6B-II was isolated frequently
in the present study. However, no serotype “6E” isolate
was identified in traditional serotype 6A with PCR.
As-yet-unconfirmed serotype “6E” has only been iden-
tified based on its capsular gene sequence [8] because
no new serotype including both traditional serotypes 6A
and 6B can be constructed within the serological typing
system [11]. If differences in gene sequences indicate
new serotypes, two new serotypes must be individually
recognized within the traditional serotypes 6A and 6B.
All the common CCs/STs included more than one
serotype or subtype, except CC90 and CC386, which in-
cluded subtype 6B-II isolates only. One subtype 6B-II
isolate belonged to CC4542, which otherwise included
only serotype 6A and subtype 6B-I isolates. However,
this isolate had a unique ST, ST8618. Two classes of cps
sequences have been reported for serogroup 6 isolates.
The class 2 cps sequences are limited to a few serotype
6B isolates [25], which are in fact subtype 6B-II. The
present data show that our subtype 6B-II isolates dis-
played genetic backgrounds different from those of other
serotypes/subtypes.
Our previous studies have suggested that a clonal shift
occurred in serotype 19F and 23F isolates between 1997
and 2010. In the serotype 19F S. pneumoniae isolates,
the spread of CC271 with high β-lactam-antibiotic resist-
ance may be driven by the selective pressure applied
with the overuse of antibiotics, whereas the spread of
susceptible CC983 is limited. CC271 became the main
population of serotype 19F S. pneumoniae after 2003
[26]. In the serotype 23F S. pneumoniae isolates, ST81
(with high β-lactam-antibiotic resistance) took the place
of ST342 and became the absolutely predominant popu-
lation in 2010 [27]. Both CC271 and ST81 are also im-
portant international epidemic clones [26,27]. We noted
that selection by antibiotic abuse caused an increase in
subtype 6B-II isolates with significantly higher β-lactam-
antibiotic resistance than that of other serogroup 6 S.
pneumoniae isolates in 1997–2008 [12]. The present
data show that most subtype 6B-II isolates belong to
CC90. ST90 is one of the globally epidemic resistant
Table 3 Resistance of serogroup 6S. pneumoniae to several antimicrobials by CCs/STs
CC/STs No. CXMa IPMa* ERYa* CHLa* TCYa SXTa MDRa
(%)I% R% I% R% R% I% R% I% R%
ST982 52 0 0 0 98.1 3.8 1.9 98.1 1.9 98.1 98.1
CC90 41 4.9 87.8 19.5 100 58.5 0 95.1 4.9 92.7 100
CC4542 25 0 0 8.0 96.0 8.0 0 100 4.0 88.0 92.0
ST2912 11 0 0 0 100 0 36.4 45.5 9.1 63.6 63.6
CC4536 15 6.7 0 0 66.7 46.7 0 100 20.0 46.7 73.3
CC2754 15 0 6.7 0 100 6.7 0 93.3 13.3 86.7 93.3
CC8616 10 0 0 10.0 90.0 10.0 0 90.0 0 90.0 90.0
CC386 10 0 0 0 100 0 10.0 80.0 0 10.0 40.0
Others 46 6.5 39.1 8.7 93.5 26.1 4.3 80.4 15.2 63.0 91.3
Total 225 2.7 24.4 6.7 95.1 21.8 3.6 90.2 7.6 78.7 89.8
Note: All 225 strains were susceptible to amoxicillin–clavulanic acid, ceftriaxone, vancomycin, and levofloxacin.
aCXM: cefuroxime; IPM: imipenem; ERY: erythromycin; CHL: chloramphenicol; TCY: tetracycline; SXT: sulfamethoxazole; MDR: multidrug resistance.
*No intermediate or resistant isolate was identified.
Table 4 Distributions of serotypes/subtypes in oral-penicillin-nonsusceptible isolates in China in 2000–2011
Years No. Serotypes/subtypes CCs/STs
6A 6B-I 6B-II CC90 CC386 CC855 CC3173 Singletons*
2000-2002 39 4(10.3%) 3(7.7%) 32(82.1%) 27(69.2%) 3(7.7%) 2(5.1%) 0(0.0%) ST76 (3), ST473,ST802, ST902, ST4545
2003-2005 9 2(22.2%) 0(0.0%) 7(77.8%) 6(66.7%) 0(0.0%) 0(0.0%) 1(11.1%) ST282,ST8742
2006-2008 12 3(25.0%) 2(16.7%) 7(58.3%) 6(50.0%) 0(0.0%) 2(16.7) 2(16.7%) ST135
2009-2011 12 6(50.0%) 1(8.3%) 5(41.7%) 2(16.7%) 1(8.3%) 2(16.7%) 5(41.7%) ST135,ST2766
Total 71 15(21.1%) 6(8.5%) 51(71.8%) 41(57.7%) 4(5.6%) 6(8.5%) 8(11.3%)
Note: No oral-penicillin-nonsusceptible strain was present in 1997–1999.
*The number of isolates is given in parentheses if more than one isolate was identified.
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clones, Spain6B-2 (http://web1.sph.emory.edu/PMEN/index.
html). CC90 isolates were the main components of the
OPNSP in our study. However, isolates belonging to this
clone decreased in 2009–2011, and its substitutes, CC855
and CC3173, did not show higher β-lactam-antibiotic re-
sistance. Therefore, this replacement cannot be explained
by antibiotic overuse and remains undefined at present.
Most of the CC855 and CC3173 isolates were identified
as serotype 6A, which is not covered by the 7-valent
pneumococcal conjugated vaccine (PCV7). The proportion
of serotype 6A isolates in the OPNSP increased signifi-
cantly (Table 4). This replacement may be attributable to
immunization with PCV7, which was used after September
2008 in China. However, this rationale is not convincing
because the vaccine immunization coverage was so low
(less than 1%) that the spread of serotypes 19F and 23F
was not restricted at all [26,27].
The MIC90 and maximum MIC of penicillin in serogroup
6 S. pneumoniae isolates remained at 1 μg/ml and 2 μg/ml,
respectively, from 2000 to 2010 in China (Table 2), whereas
the MIC90 of serotypes 19 F and 23 F increased to 2 μg/ml
and the maximum value was 8 μg/ml, and even reached
256 μg/ml [28,29]. The present data also show the absence
of salient resistant clones in serogroup 6 S. pneumoniae.
They all may be under antibiotic selective pressure. There-
fore, the CC/ST components of this group have not chan-
ged regularly, like serotypes 19 F and 23 F. This speculation
corresponds to the decreasing frequency of serogroup 6
among all S. pneumoniae isolates over time [12]. The
population biology of this serogroup should be moni-
tored continuously in the future.
Conclusions
In summary, this study clarifies the serotypes/subtypes
and CCs/STs of group 6 S. pneumoniae present in China.
Serotype “6E” was not identified in the traditional 6A iso-
lates, and neither serotype “6 F” nor “6G” was assigned in
our collection. Although the subtype 6B-II isolates were
the main constituents of the OPNSP, their place was taken
by serotype 6A isolates over time. The genetic constitution
of the group 6 S. pneumoniae and its changes showed dis-
tinct regional characters. Unlike the serotype 19 F and
23 F isolates, no salient resistant clones were identified in
serogroup 6 S. pneumoniae. Further long-term surveys of
serogroup 6 S. pneumoniae are required to monitor the
clonal prevalence and antimicrobial resistance in this im-
portant human pathogen.
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